A Phase 1 Dose Escalation Study of VX-973 in Healthy Participants
Clinical trial NCT06615570 · COMPLETED
Trial details
- NCT number
- NCT06615570
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2025-07-21
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.